Invention Grant
- Patent Title: Substituted 4-hydroxypyrimidine-5-carboxamides
- Patent Title (中): 取代的4-羟基嘧啶-5-甲酰胺
-
Application No.: US13379536Application Date: 2010-06-21
-
Publication No.: US08815865B2Publication Date: 2014-08-26
- Inventor: Matthew J. Clements , John S. Debenham , Jeffrey J. Hale , Christina Madsen-Duggan
- Applicant: Matthew J. Clements , John S. Debenham , Jeffrey J. Hale , Christina Madsen-Duggan
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Matthew A. Leff; Valerie J. Camara
- International Application: PCT/US2010/039289 WO 20100621
- International Announcement: WO2011/002623 WO 20110106
- Main IPC: A61K31/501
- IPC: A61K31/501 ; A61K31/4965 ; C07D401/06 ; C07D239/02
Abstract:
The present invention relates to substituted 4-hydroxypyrimidine-5-carboxamides useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.
Public/Granted literature
- US20120108600A1 SUBSTITUTED 4-HYDROXYPYRIMIDINE-5-CARBOXAMIDES Public/Granted day:2012-05-03
Information query
IPC分类:
